Paraneoplastic neurological autoimmunity and survival in small-cell lung cancer

Journal of Neuroimmunology

Volumn 201-202, Issue C, 2008, Pages 159-162

  Maddison, Paul ^a   Lang, Bethan ^b  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Lambert Eaton myasthenic syndrome; Onconeural antibodies; Small cell lung cancer; Survival; Voltage gated calcium channels

Indexed keywords

VOLTAGE GATED CALCIUM CHANNEL;

AGED; ARTICLE; AUTOIMMUNITY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; EATON LAMBERT SYNDROME; ELECTROPHYSIOLOGY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSURVEILLANCE; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; SENSORY NEUROPATHY; SURVIVAL RATE;

ANTIBODIES; CALCIUM CHANNELS; HUMANS; IMMUNOPRECIPITATION; LUNG NEOPLASMS; PARANEOPLASTIC SYNDROMES; SMALL CELL LUNG CARCINOMA; SURVIVAL ANALYSIS;

EID: 51649106356     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.05.024     Document Type: Article

References (19)

1. Albert M.L., Darnell J.C., Bender A., Francisco L.M., Bhardwaj N., and Darnell R.B. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat. Med. 4 (1998) 1321-1324
2. Darnell R.B., and Posner J.B. Paraneoplastic syndromes affecting the nervous system. Semin. Oncol. 33 (2006) 270-298
3. Elrington G.M., Murray N.M., Spiro S.G., and Newsom-Davis J. Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients. J. Neurol. Neurosurg. Psychiatry 54 (1991) 764-767
4. Graus F., Delattre J.Y., Antoine J.C., Dalmau J., Giometto B., Grisold W., Honnorat J., Smitt P.S., Vedeler Ch., Verschuuren J.J., Vincent A., and Voltz R. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J. Neurol. Neurosurg. Psychiatry 75 (2004) 1135-1140
5. Graus F., Dalmou J., Reñé R., Tora M., Malats N., Verschuuren J.J., Cardenal F., Viñolas N., Garcia del Muro J., Vadell C., Mason W.P., Rosell R., Posner J.B., and Real F.X. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J. Clin. Oncol. 15 (1997) 2866-2872
6. Gudermann T., and Roelle S. Calcium-dependent growth regulation of small cell lung cancer cells by neuropeptides. Endocr. Relat. Cancer 13 (2006) 1069-1084
7. Jackman D.M., and Johnson B.E. Small-cell lung cancer. Lancet 366 (2005) 1385-1396
8. Lang B., Newsom-Davis J., Peers C., Prior C., and Wray D.W. The effect of myasthenic syndrome antibody on presynaptic calcium channels in the mouse. J. Physiol. (Lond.) 390 (1987) 257-270
9. Maddison P., Newsom-Davis J., Mills K.R., and Souhami R.L. Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma. Lancet 353 (1999) 117-118
10. Mason W.P., Graus F., Lang B., Honnorat J., Delattre J.Y., Valldeoriola F., Antoine J.C., Rosenblum M.K., Rosenfeld M.R., Newsom-Davis J., Posner J.B., and Dalmau J. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain 120 (1997) 1279-1300
11. Monstad S.E., Drivsholm L., Storstein A., Aarseth J.H., Haugen M., Lang B., Vincent A., and Vedeler C.A. Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer. J. Clin. Oncol. 22 (2004) 795-800
12. Morris C.S., Esiri M.M., Marx A., and Newsom-Davis J. Immunocytochemical characteristics of small cell lung carcinoma associated with the Lambert-Eaton myasthenic syndrome. Am. J. Pathol. 140 (1992) 839-845
13. Motomura M., Johnston I., Lang B., Palace J., Vincent A., and Newsom-Davis J. An improved diagnostic assay for Lambert-Eaton myasthenic syndrome. J. Neurosci. 147 (1997) 35-42
14. Oh S.J., Kurokawa K., Claussen G.C., and Ryan Jr. H.F. Electrophysiological diagnostic criteria of Lambert-Eaton myasthenic syndrome. Muscle Nerve 32 (2005) 515-520
15. O'Neill J.H., Murray N.M., and Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain 111 (1988) 577-596
16. Pinto A., Iwasa K., Newland C., Newsom-Davis J., and Lang B. Action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channels. Muscle Nerve 25 (2002) 715-724
17. 1A calcium channel subunit reduce both P-type and Q-type calcium channels in cerebellar neurons. PNAS 95 (1998) 8328-8333
18. Roberts A., Perera S., Lang B., Vincent A., and Newsom-Davis J. Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line. Nature 317 (1985) 737-739
19. Wirtz P.W., Lang B., Graus F., van den Maagdenberg A.M., Saiz A., de Koning Gans P.A., Twijnstra A., and Verschuuren J.J. P/Q-type calcium channel antibodies, Lambert-Eaton myasthenic syndrome and survival in small cell lung cancer. J. Neuroimmunol. 164 (2005) 161-165